Mahesh Choolani

Title: Mahesh Choolani: Innovator in Medical Technology

Introduction

Mahesh Choolani is a prominent inventor based in Singapore, known for his contributions to medical technology. He holds 3 patents that focus on innovative methods for wound treatment and cellular analysis. His work has the potential to significantly impact the field of regenerative medicine.

Latest Patents

One of Mahesh Choolani's latest patents is a wound dressing nanomesh impregnated with human umbilical cord Wharton's jelly stem cells. This invention is directed to a method of treating wounds, particularly to suppress scar formation. The method involves contacting the wound with a composition that includes Wharton's jelly stem cells, a conditioned cell culture medium, and other related components. Another notable patent is a method of identifying, isolating, and culturing fetal erythroblasts. This method analyzes the morphology of cells in a sample to identify nucleated cells that are CD45 negative and have a high cytoplasmic to nuclear ratio, thus identifying them as fetal erythroblasts.

Career Highlights

Mahesh Choolani has worked at the National University of Singapore, where he has contributed to various research projects and innovations in the medical field. His expertise in stem cell research and regenerative medicine has positioned him as a key figure in advancing medical technologies.

Collaborations

Throughout his career, Mahesh has collaborated with notable colleagues, including Chui Yee Fong and Arijit Biswas. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Mahesh Choolani's work exemplifies the intersection of innovation and medical technology. His patents and research contributions are paving the way for advancements in wound treatment and cellular analysis. His dedication to improving healthcare through innovative solutions is commendable.